(NASDAQ: CGNX) Cognex's forecast annual revenue growth rate of 9.5% is forecast to beat the US Scientific & Technical Instruments industry's average forecast revenue growth rate of 7.58%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.71%.
Cognex's revenue in 2026 is $994,359,000.On average, 25 Wall Street analysts forecast CGNX's revenue for 2026 to be $180,455,924,880, with the lowest CGNX revenue forecast at $168,193,538,800, and the highest CGNX revenue forecast at $192,718,310,960. On average, 24 Wall Street analysts forecast CGNX's revenue for 2027 to be $196,032,469,360, with the lowest CGNX revenue forecast at $175,816,103,120, and the highest CGNX revenue forecast at $216,745,959,360.
In 2028, CGNX is forecast to generate $218,403,038,560 in revenue, with the lowest revenue forecast at $197,689,548,560 and the highest revenue forecast at $242,762,102,800.